Brief: Amgen Says On June 22, FTC Filed Administrative Complaint Alleging Co's Proposed Acquisition Of Horizon Would Violate Federal Antitrust Laws - SEC Filing
Aug 4 (Reuters) - Amgen Inc AMGN.O :
* AMGEN: ON JUNE 22, FTC FILED ADMINISTRATIVE COMPLAINT
ALLEGING
CO'S PROPOSED ACQUISITION OF HORIZON WOULD VIOLATE FEDERAL
ANTITRUST LAWS - SEC FILING
* AMGEN INC: ON JULY 7, AMGEN AND HORIZON FILED ANSWER TO
THE
ADMINISTRATIVE COMPLAINT
Source text for Eikon: ID:
Further company coverage: AMGN.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Horizon Therapeutics
See all newsDeals of the day-Mergers and acquisitions
Amgen completes $27.8 bln Horizon deal (updated)
Amgen completes acquisition of Horizon Therapeutics
Brief: Amgen Completes Acquisition Of Horizon Therapeutics PLC
On October 5, Court Sanctioned The Scheme Of Arrangement Under Chapter 1 Of Part 9 Of The Irish Companies Act 2014